IGF1R Protein Expression Is Not Associated with Differential Benefit to Concurrent Trastuzumab in Early-Stage HER2 + Breast Cancer from the North Central Cancer Treatment Group (Alliance) Adjuvant Trastuzumab Trial N9831
Reinholz, Monica M., Chen, Beiyun, Dueck, Amylou C., Tenner, Kathleen, Ballman, Karla, Riehle, Darren, Jenkins, Robert B., Geiger, Xochiquetzal J., McCullough, Ann E., Perez, Edith A.Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-15-0574
Date:
May, 2017
File:
PDF, 681 KB
english, 2017